10 Buzzing AI Health Stocks 

Page 7 of 10

4. Abbott Laboratories (NYSE:ABT)

Number of Hedge Fund Holders: 69

Abbott Laboratories (NYSE:ABT) makes and sells healthcare products. The firm has embraced AI in diagnostics, particularly in its Alinity and FreeStyle Libre systems. The company uses AI to improve the accuracy of its continuous glucose monitoring systems and to enhance its diagnostics platforms. These AI-driven tools help healthcare providers make more informed decisions, improving patient outcomes and reducing the burden on healthcare systems.

In terms of financial performance, Abbott reported $43.1 billion in revenue for 2023, up 7% from $40.3 billion in 2022. The growth was primarily driven by increased demand for its AI-powered diagnostics tools, particularly in the diabetes care segment, where the FreeStyle Libre system saw a 12% increase in sales. Abbott’s continuous investment in AI is expected to contribute to sustained revenue growth as demand for accurate diagnostics rises.

Page 7 of 10